NSCLC cells treated with etoposide in the presence of recombinant TGFBI displayed higher caspase 3/7 activity compared to cells treated with the chemotherapeutic drug alone (Figure 4C). The gene discussed is TGFBI; the disease is non-small cell lung carcinoma.